The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen ...